ARL11 Gene Tumor Predisposition Syndrome ARL11 Related NGS Genetic DNA Test
Introduction to the Test
The ARL11 Gene Tumor Predisposition Syndrome ARL11 Related NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify genetic mutations associated with an increased risk of cancer. This test is particularly important for individuals with a family history of cancer, as it provides critical information that can guide clinical management and preventive strategies.
What the Test Measures
This genetic test employs Next-Generation Sequencing (NGS) technology to analyze the ARL11 gene, detecting any mutations that may predispose individuals to tumor development. By understanding these genetic factors, patients can take proactive steps towards their health.
Who Should Consider This Test?
Individuals with the following characteristics should consider the ARL11 Gene Tumor Predisposition Syndrome ARL11 Related NGS Genetic DNA Test:
- Family history of cancer, especially involving the ARL11 gene.
- Symptoms indicative of genetic predisposition to cancer.
- Consultation with an oncologist regarding potential genetic risks.
Benefits of Taking the Test
Taking the ARL11 Gene Tumor Predisposition Syndrome ARL11 Related NGS Genetic DNA Test offers numerous benefits:
- Early identification of cancer risk, allowing for timely preventive measures.
- Informed decision-making regarding treatment options and monitoring.
- Guidance for family members regarding their own cancer risk.
Understanding Your Results
Once the test is complete, results will be analyzed and discussed with a qualified healthcare professional. Understanding your results is crucial, as they can influence your health management strategies. The interpretation of results will consider your family history and any clinical symptoms present.
Test Pricing
Test Name | Discount Price | Regular Price |
---|---|---|
ARL11 Gene Tumor Predisposition Syndrome ARL11 Related NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood, extracted DNA, or even one drop of blood on an FTA card. Prior to testing, it is recommended to have a genetic counseling session to draw a pedigree chart of family members affected by the ARL11 Gene Tumor predisposition syndrome.
Book Your Test Today!
We have branches across all major cities in Kenya, making it easy for you to access our services. For home sample collection or to book your test, please call or WhatsApp us at +254711564616.